Trending Now
Sio Gene Therapies Inc. (NASDAQ:SIOX) Announces Encouraging Follow-Up Results From Low...
Sio Gene Therapies Inc. (NASDAQ:SIOX) has reported positive six-month follow-up data from its low-dose cohort of the dose-escalation study of AXO-AAV-GM1. AXO-AAV-GM1...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
As Crypto Heats Up, APLD and BLQC Catch Fire on Hosting...
Bitcoin has been a relatively reliable leading indicator of risk appetite across global assets over the past year, leading Ark stocks and the Nasdaq...
MAKE IT MODERN
LATEST REVIEWS
Liquidia Corp (NASDAQ: LQDA) Will Have a Presentation on YUTREPIA
Liquidia Corporation (NASDAQ: LQDA) has announced a presentation on YUTREPIA studies by Dr Samdeep Sahay. The drug, which is still under investigation, is a...
MAKE IT MODERN
PERFORMANCE TRAINING
Merus N.V. (MRUS): A Deep Dive into the Cancer-Focused Biotech’s Recent Surge
Merus N.V. (NASDAQ: MRUS), a clinical-stage oncology company, has been gaining significant attention in the biotech sector. Specializing in innovative cancer therapies,...
Why TAAT Global Alternatives Inc could be a threat to the tobacco industry (TOBAF,...
The tobacco industry has been a darling of investors in the 20th century. Tobacco stocks were among the best performers, benefiting from...
Vaxart Inc. (NASDAQ:VXRT) Picks Its Lead Oral Coronavirus Vaccine Candidate And Contracts KindredBio As...
Vaxart Inc. (NASDAQ:VXRT) has announced that it has chosen its lead coronavirus vaccine candidate as well as contracted KindredBio to produce the vaccine in...
The Big Picture for Virus Testing Stocks (FLGT, ALST, CODX)
The good news is that the end of the pandemic is in sight. The bad news is that it may never really...
Sorrento Therapeutics Inc. (NASDAQ: SRNE) Receives Approval From ANVISA To Commence Phase 2A Study...
Sorrento Therapeutics Inc. (NASDAQ: SRNE) has received approval from the Brazilian Regulatory Agency (ANVISA) to go on with the Phase 2A placebo-controlled, randomized trial...
MAKE IT MODERN
